Clinical Trial Update: Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

View source ↗

Summary

It discusses strategies for treating metastatic bladder cancer in patients ineligible for cisplatin and examines how geriatric assessments can inform treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Bladder Cancer, Metastatic Bladder Cancer | Status: RECRUITING